Post Operative Atrial Fibrillation Post Cardiac Surgery ( CABG and VALVE REPLACEMENT )

Launched by ASSIUT UNIVERSITY · Jan 1, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a condition called postoperative atrial fibrillation, which is an irregular heartbeat that can happen after heart surgery. Specifically, the study will focus on patients undergoing their first planned cardiac surgeries, such as coronary artery bypass grafting (CABG) and valve replacement, at Assiut University Heart Hospital. The researchers want to understand how often this condition occurs and what risk factors might contribute to it.

To be eligible for this study, participants must be at least 18 years old and scheduled for one of these surgeries. They should not have a history of heart surgery before and must currently be in a stable heart rhythm without taking certain heart medications, except for specific types. If you choose to participate, you’ll be asked to provide informed consent, meaning you agree to be part of the study after understanding its purpose. The study is not yet recruiting participants, and it’s essential to know that individuals with certain medical conditions, like hyperthyroidism or electrolyte disturbances, will not be included. This trial aims to improve our understanding of heart health after surgery, which could lead to better care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. ≥18 years scheduled for first-time planned cardiac surgery ( CABG and Valve replacement)
• • 2. Patients who are in sinus rhythm and not taking any antiarrhythmic medication, other than beta-adrenergic blocking agents, at the time of surgery.
• • 3. Willingness to participate and provision of informed consent
• Exclusion Criteria:
• • 1. Prior history of cardiac surgery.
• • 2. Pediatric population less than 18 years.
• • 3. Patients with history of hyperthyroidism
• • 4. Patients with electrolyte disturbance
• • 5. Where follow-up is not possible.
• • 6. The patient refused to sign the informed consent to participate in the research.